Saudi German Health 2021 profit slumps 79% to SAR 17.2 mln, turns to SAR 18.4 mln loss in Q4

31/03/2022 Argaam Exclusive

View other reports

Share Price

89.30
(0.90) (1.00 %)

Middle East Healthcare Co. (SAUDI GERMAN HEALTH)

Middle East Healthcare Co.’s (Saudi German Health) net profit after Zakat and tax plunged 79% to SAR 17.2 million in 2021, from SAR 82 million in the previous year, as re-branding led to higher selling and marketing expenses.



Financials (M)

Item 2020 2021 Change‬
Revenues 1,750.59 1,872.62 7.0 %
Gross Income 578.37 608.18 5.2 %
Operating Income 107.41 40.50 (62.3 %)
Net Income 81.99 17.20 (79.0 %)
Average Shares 92.04 92.04 -
EPS (Riyals) 0.89 0.19 (79.0 %)

The group also noted an increase in consultancy expenses due to cost optimization project, and higher financial costs and accrual of Zakat.

 

Saudi German Health swung to a net loss after Zakat and tax of SAR 18.4 million in Q4 2021, from a profit of SAR 9.5 million in Q4 2020.

 

On a sequential basis, the firm posted a loss versus a profit of SAR 14.35 million in Q3 2021.



Current Quarter Comparison (M)

Compared With The
Item Q4 2020 Q4 2021 Change‬
Revenues 448.89 498.95 11.2 %
Gross Income 139.12 160.11 15.1 %
Operating Income 17.20 (7.03) (140.9 %)
Net Income 9.54 (18.39) (292.8 %)
Average Shares 92.04 92.04 -
EPS (Riyals) 0.10 (0.20) (292.8 %)

Shareholders’ equity, after minority interest, increased 2.1% year-on-year to SAR 1.257 billion in 2021.

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.